Oct 11, 2021
The second round of the Presidential Clinical Research Partnership (PCRP) program awarded five grants totaling $1 million to interdisciplinary projects that support the development of long-term partnerships between Texas A&M University and its clinical affiliates and partners, the Division of Research announced today. These awards are available for up to $200,000 for a two-year period.
The Presidential Clinical Research Partnership Grants program is part of the President’s Excellence Fund. The program supports the development of long-term partnerships between Texas A&M University and our clinical affiliates and partners leading to the highest level of health for all Texans. The program aims to foster interdisciplinary research that will improve health, health care and/or health equity in Texas by advancing novel translational, clinical, or educational research targeting topics such as: treatment or prevention of injury or disease, health promotion in the clinical setting and/or health disparities; improved diagnoses or disease management; health policy or health care delivery issues, such as quality and cost of care, access to care and community health interventions with opportunities to demonstrably improve health outcomes; and innovative training and development of future health and health care professionals and/or biomedical scientists to better address statewide health needs and health care practices.
Clinical Research Partnership Grants must be co-led by faculty or faculty-equivalent research positions at Texas A&M, Texas A&M University at Galveston, Texas A&M University at Qatar, Texas A&M Engineering Experiment Station (TEES), Texas A&M Engineering Extension Service (TEEX), Texas A&M AgriLife Research, Texas A&M AgriLife Extension, or the Texas A&M Transportation Institute (TTI), and clinical practitioners at healthcare facilities with established affiliation or clinical research collaboration agreements. Additional team members may consist of any faculty or staff with appropriate expertise for the team. The maximum award is $200,000 over a two-year period.
The program supports clinical research defined by NIH as: 1. Patient-oriented research. Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. Excluded from this definition are in vitro studies that utilize human tissues that cannot be linked to a living individual. Patient-oriented research includes: (a) mechanisms of human disease, (b) therapeutic interventions, (c) clinical trials, or (d) development of new technologies. 2. Epidemiologic and behavioral studies. 3. Outcomes research and health services research.